Financials

  • Market Capitalization 1.91 B
  • Employee 367
  • Founded 2016
  • CEO Marianne De Backer
  • Website www.vir.bio
  • Headquarter Delaware, United States
  • FIGI BBG00H2QQ8T5
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.91
Fiyat/satışlar oranı
12.18

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
1953
FTRE
Fortrea Holdings Inc. - Common Stock
21.00 USD+0.77%-4.55%+21.95%+103.49%2.00 B USD
1961
MLYS
Mineralys Therapeutics, Inc. - Common Stock
22.23 USD-4.88%-5.56%-21.00%-44.93%1.97 B USD
1978
XERS
Xeris Biopharma Holdings, Inc. - Common Stock
10.46 USD-0.19%+2.25%+37.81%+30.75%1.91 B USD
1990
URGN
UroGen Pharma Ltd. - Ordinary Shares
38.28 USD+3.94%-11.47%-9.63%+101.47%1.87 B USD

Haberler